The March 2022 issue of Plastic and Reconstructive Surgery (Volume 10, Issue 3) featured the first prospective study evaluating a handsfree thermoregulated bipolar radiofrequency device for face and neck contouring. The study, titled “A Prospective Trial: Handsfree Thermoregulated Bipolar Radiofrequency for Face and Neck Contouring”, is authored by Erez Dayan, MD, Anne Chapas, MD, and Joseph Marte, MD, and Park Avenue Smart Lipo™ plastic surgeons Christopher Chia, MD and Spero Theodorou, MD.
The study prospectively evaluated InMode’s EVOKE, the first “hands free” thermoregulated noninvasive bipolar radiofrequency technology which is specifically intended to target soft tissue laxity in the lower one-third of the face. The study’s primary goal was to evaluate safety and soft tissue remodeling pretreatment at one, three and six months post last treatment. The findings indicate that more patients were satisfied at the three month follow-up compared with the one month follow-up for all three measures. The evaluation concluded that the EVOKE device demonstrates a significant advance in the control and delivery of radiofrequency for aesthetic purposes.
